CDK2 antibody (Cyclin-Dependent Kinase 2)

Details for Product anti-CDK2 Antibody No. ABIN967341, Supplier: Log in to see
Antigen
  • MGC84068
  • cinp
  • CINP
  • p33(CDK2)
  • A630093N05Rik
  • wu:fa10c02
  • zgc:56598
  • zgc:77684
  • eg1
  • CDKN2
  • cdk2L
  • MGC84068 protein
  • cyclin-dependent kinase 2 interacting protein
  • Cyclin-dependent kinase 2-interacting protein
  • cyclin dependent kinase 2
  • cyclin-dependent kinase 2
  • cyclin-dependent kinase 2 (CDK2)
  • cyclin-dependent kinase-2 alpha
  • MGC84068
  • CINP
  • cinp
  • Cdk2
  • CDK2
  • cdk2
  • LOC100154715
Alternatives
anti-Human CDK2 antibody for Western Blotting
Reactivity
Human
434
266
174
62
19
18
15
15
14
13
11
11
8
5
4
4
3
2
1
Host
Rabbit
333
159
1
Clonality
Polyclonal
Conjugate
This CDK2 antibody is un-conjugated
25
18
16
12
8
8
7
7
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
Application
Immunoprecipitation (IP), Western Blotting (WB)
418
213
129
99
78
69
58
39
32
18
11
8
3
3
2
2
2
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Isotype Ig
Cross-Reactivity Mouse (Murine)
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
3. Please refer to us for technical protocols.
Purification Purified from antiserum by affinity chromatography.
Components 1) 51-9000091: Polyclonal Rabbit Anti-Cdk2.
Quantity: 0.1 ml (1 ea).
Immunogen: Human Cdk2 aa. 287-298 Peptide.
Molecular Weight: 33 kDa.
Storage Buffer: Aqueous buffered solution containing Less or equal than 0.09% sodium azide.

2) 51-16516N: HeLa Control Lysate.
Quantity: 50 µg (1 ea).
Concentration: 1.0 mg/ml.
Storage Buffer: SDS-PAGE buffer (62mM Tris pH 6.8, 2% SDS, 0.9% b-mercaptoethanol, 0.003% bromophenol blue, 5% glycerol).
Alternative Name Cdk2 (CDK2 Antibody Abstract)
Background Cyclins and cyclin-dependent kinases (cdks) are evolutionarily conserved proteins that are essential for cell cycle control in eukaryotes. Cdks are catalytic subunits whose activity requires interaction with their regulatory subunits, the cyclins, as well as specific phosphorylation events. The precise timing of cyclin-cdk activity during the cell cycle determines whether the cell cycle continues or becomes blocked. Cdks 2, 4, 5, and 6 may associate with D-type cyclins. Interaction between cdk2 and cyclin E during G1/S transition creates a complex with histone H1 kinase activity. This complex is thought to be required for the initiation and progression of DNA replication during S phase. Cdk2-cyclin A complexes appear during late S phase and also play a role in progression of DNA replication. Substrates for cdk-cyclin complexes include nuclear lamins, histones, oncogenes, (c-src, c-abl, SV40 large-T), tumor suppressor genes (e.g., RB and p53), nucleolin, RNA polymerase II and others. A synthetic peptide corresponding to amino acids 287-298 (QDVTKPVPHLRL) at the C-terminus of human cdk2, with the addition of a C-terminal cysteine residue (C) to facilitate coupling to KLH, was used as immunogen to generate this antibody.
Molecular Weight 33 kDa
Research Area Cancer, Cell Cycle, Kinases/Phosphatases
Pathways PI3K-Akt Signaling, Cell Division Cycle, Mitotic G1-G1/S Phases, DNA Replication, M Phase, Synthesis of DNA
Comment

Related Products: ABIN967390, ABIN968535

Restrictions For Research Use only
Format Liquid
Concentration 1.0 mg/ml
Buffer Aqueous buffered solution.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Supplier Images
Western Blotting (WB) image for anti-Cyclin-Dependent Kinase 2 (CDK2) antibody (ABIN967341) Western blot analysis for Cdk2. A HeLa cell lysate (Human cervical epitheloid carcino...
Product cited in: Heichman, Roberts: "Rules to replicate by." in: Cell, Vol. 79, Issue 4, pp. 557-62, 1994 (PubMed).

Hunter, Pines: "Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age." in: Cell, Vol. 79, Issue 4, pp. 573-82, 1994 (PubMed).

Peter, Herskowitz: "Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle." in: Cell, Vol. 79, Issue 2, pp. 181-4, 1994 (PubMed).

Sherr: "G1 phase progression: cycling on cue." in: Cell, Vol. 79, Issue 4, pp. 551-5, 1994 (PubMed).

Zhang, Xiong, Beach: "Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes." in: Molecular biology of the cell, Vol. 4, Issue 9, pp. 897-906, 1994 (PubMed).

Xiong, Zhang, Beach: "Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation." in: Genes & development, Vol. 7, Issue 8, pp. 1572-83, 1993 (PubMed).

Did you look for something else?